Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2025-12-26 @ 11:11 AM
NCT ID:
NCT05212428
Eligibility Criteria:
Inclusion Criteria:
* Age \>= 18 years
* Registered Mayo Clinic patient
* Able to provide informed written consent
* E-mail and web access (for electronic consent, video education, registering with Helix and receiving results)
* Ability to collect and ship saliva sample within the United States
* Of note: Women, who are pregnant, or planning to become pregnant, can take part in this study. However, this study does not replace prenatal genetic testing. If participants have these concerns, they will be encouraged to contact their obstetrics (OB) provider or a genetic counselor to discuss further
Exclusion Criteria:
* Other co-morbidity which would in physician's opinion interferes with patient's ability to participate in the study (eg: reduced ability to comprehend eg: dementia, intellectual disability, fluency in consent language)
* Allogeneic bone marrow transplant (e.g. samples from autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant)
* Active hematological cancer or history of a hematological cancer
* Resident of the state of New York
* The Helix lab does not currently have New York state licensure
* Residents without a shipping address in the United States
* The Helix lab is unable to ship and receive samples internationally
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05212428
Study Brief:
Protocol Section:
NCT05212428